Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Urinary Bladder Neoplasms: HELP
Anna Orsola
Based on 19 articles published since 2007
||||
Expertise Level
The expertise of Anna Orsola ranks in the Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Orsola, Anna   ·   Orsola, A
Work Locations
Details
Most likely:    Harvard University   Contact    
2017
  • Department of Urology, Hospital Universitari GermansTrias i Pujol and Autonomous University of Barcelona, Barcelona, Spain. · Dana-Farber Cancer Institute, Boston, MA. Electronic address: · Medical Oncology Service, Department of Medicine, Catalan Institute of Oncology, Hospital Universitari GermansTrias i Pujol and Autonomous University of Barcelona, Barcelona, Spain. · Pubmed 28274590
  • Department of Urology, Hospital Universitari Germans Trias i Pujol and Autonomous University of Barcelona, Barcelona, Spain. · Bladder Cancer Center, Dana-Farber Cancer Institute, Boston, MA. Electronic address: · Medical Oncology Service, Department of Medicine, Catalan Institute of Oncology, Hospital Universitari GermansTrias i Pujol and Autonomous University of Barcelona, Barcelona, Spain. · Pubmed 27364982
2016
  • Departement of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Departement of Medical Oncology, Brigham and Women's Cancer Center, Brigham and Women's Cancer Center, Boston, MA 02115, USA. · Departement of Medical Oncology, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA. · The Eli and Edythe L. Broad Institute, 415 Main Street, Cambridge, MA 02142, USA. · Departement of Medical Oncology, University of Alabama at Birmingham (UAB), 1720 2nd Avenue S, Birmingham, AL 35233, USA. · Pubmed 27351382
  • Bladder Cancer Center, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Bladder Cancer Center, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 27806880
2015
  • Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. Electronic address: · Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA. · Pubmed 25935702
  • Bladder Cancer Center, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02115, USA. Electronic address: · Urology Department, Fundacio Puigvert, Cartagena 340-350, Barcelona 08025, Spain. · Urology Department, Instituto Valenciano de Oncologia, Calle del Profesor Beltrán Bàguena, 8, València 46009, Spain. · Pubmed 25836931
  • Department of Oncology, Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA 02215, USA. · Departments of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Department of Pathology, Vall d'Hebron Hospital, Barcelona 08035, Spain. · University of Massachusetts Medical School, Worcester, MA 01655, USA. · Department of Urology, Vall d'Hebron Hospital, Barcelona 08035, Spain. · 1] Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA 02215, USA [2] Division of Urology, Brigham and Women's Hospital, Boston, MA 02215, USA. · Department of Pathology, Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA 02215, USA. · Pubmed 25535728
  • Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA. · Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA; University Hospital del Mar-IMIM, Barcelona, Spain · Pubmed 26195703
2015
  • William Martin-Doyle, University of Massachusetts Medical School, Worcester; Jeffrey J. Leow, Steven L. Chang, and Joaquim Bellmunt, Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School; Jeffrey J. Leow and Steven L. Chang, Brigham and Women's Hospital, Harvard Medical School; Anna Orsola, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and Joaquim Bellmunt, University Hospital del Mar d'Investigacions Médiques, IMIM, Barcelona, Spain. · William Martin-Doyle, University of Massachusetts Medical School, Worcester; Jeffrey J. Leow, Steven L. Chang, and Joaquim Bellmunt, Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School; Jeffrey J. Leow and Steven L. Chang, Brigham and Women's Hospital, Harvard Medical School; Anna Orsola, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and Joaquim Bellmunt, University Hospital del Mar d'Investigacions Médiques, IMIM, Barcelona, Spain. · Pubmed 25559810
2013
  • Laboratoy Recerca IMIM, University Hospital del Mar, Barcelona, Spain. · Pubmed 23851383
Probable:    Universitat Autonoma de Barcelona      
2014
  • Department of Medical Oncology, University Hospital del Mar-IMIM, Barcelona, Spain Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, USA. · Department of Urology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Radio Oncology, University Hospital Ulm, Ulm, Germany. · Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef- Spital, Vienna, Austria. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · Pubmed 25096609
2010
  • Department of Urology, Hospital Vall d'Hebron, Barcelona, Spain. · Pubmed 19558557
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 19 total) written by Anna Orsola about Urinary Bladder Neoplasms:

  • Role of Inflammation in the Perioperative Management of Urothelial Bladder Cancer With Squamous-Cell Features: Impact of Neutrophil-to-Lymphocyte Ratio on Outcomes and Response to Neoadjuvant Chemotherapy. 2017
  • Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer. 2017
  • Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy. 2016
  • Letter to the Editor, Re: van der Heijden AG, Mengual L, Lozano JJ, Ingelmo-Torres M, Ribal MJ, Fernández PL, Oosterwijk E, Schalken JA, Alcaraz A, Witjes JA. A five-gene expression signature to predict progression in T1G3 bladder cancer. Eur J Cancer. 2016; 64:127-136. 2016
  • Precision and predictive medicine in urothelial cancer: are we making progress? 2015
  • High-risk nonmuscle invasive bladder cancer. 2015
  • Improving selection criteria for early cystectomy in high-grade t1 bladder cancer: a meta-analysis of 15,215 patients. 2015
  • Reexamining treatment of high-grade T1 bladder cancer according to depth of lamina propria invasion: a prospective trial of 200 patients. 2015
  • Reply to K. Lu. 2015
  • Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up. 2014
Show List of Full Article Records
Google Searches

Learn more about Anna Orsola using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Harvard University
Universitat Autonoma de Barcelona
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Harvard University
2017
  • Department of Urology, Hospital Universitari GermansTrias i Pujol and Autonomous University of Barcelona, Barcelona, Spain. · Dana-Farber Cancer Institute, Boston, MA. Electronic address: · Medical Oncology Service, Department of Medicine, Catalan Institute of Oncology, Hospital Universitari GermansTrias i Pujol and Autonomous University of Barcelona, Barcelona, Spain. · Pubmed 28274590
  • Department of Urology, Hospital Universitari Germans Trias i Pujol and Autonomous University of Barcelona, Barcelona, Spain. · Bladder Cancer Center, Dana-Farber Cancer Institute, Boston, MA. Electronic address: · Medical Oncology Service, Department of Medicine, Catalan Institute of Oncology, Hospital Universitari GermansTrias i Pujol and Autonomous University of Barcelona, Barcelona, Spain. · Pubmed 27364982
2016
  • Departement of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Departement of Medical Oncology, Brigham and Women's Cancer Center, Brigham and Women's Cancer Center, Boston, MA 02115, USA. · Departement of Medical Oncology, Harvard Medical School, 25 Shattuck Street, Boston, MA 02115, USA. · The Eli and Edythe L. Broad Institute, 415 Main Street, Cambridge, MA 02142, USA. · Departement of Medical Oncology, University of Alabama at Birmingham (UAB), 1720 2nd Avenue S, Birmingham, AL 35233, USA. · Pubmed 27351382
  • Bladder Cancer Center, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Bladder Cancer Center, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 27806880
2015
  • Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. Electronic address: · Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA. · Pubmed 25935702
  • Bladder Cancer Center, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02115, USA. Electronic address: · Urology Department, Fundacio Puigvert, Cartagena 340-350, Barcelona 08025, Spain. · Urology Department, Instituto Valenciano de Oncologia, Calle del Profesor Beltrán Bàguena, 8, València 46009, Spain. · Pubmed 25836931
  • Department of Oncology, Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA 02215, USA. · Departments of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Department of Pathology, Vall d'Hebron Hospital, Barcelona 08035, Spain. · University of Massachusetts Medical School, Worcester, MA 01655, USA. · Department of Urology, Vall d'Hebron Hospital, Barcelona 08035, Spain. · 1] Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA 02215, USA [2] Division of Urology, Brigham and Women's Hospital, Boston, MA 02215, USA. · Department of Pathology, Dana-Farber/Brigham and Women's Hospital Cancer Center, Harvard Medical School, Boston, MA 02215, USA. · Pubmed 25535728
  • Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA. · Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA; University Hospital del Mar-IMIM, Barcelona, Spain · Pubmed 26195703
2015
  • William Martin-Doyle, University of Massachusetts Medical School, Worcester; Jeffrey J. Leow, Steven L. Chang, and Joaquim Bellmunt, Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School; Jeffrey J. Leow and Steven L. Chang, Brigham and Women's Hospital, Harvard Medical School; Anna Orsola, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and Joaquim Bellmunt, University Hospital del Mar d'Investigacions Médiques, IMIM, Barcelona, Spain. · William Martin-Doyle, University of Massachusetts Medical School, Worcester; Jeffrey J. Leow, Steven L. Chang, and Joaquim Bellmunt, Bladder Cancer Center, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School; Jeffrey J. Leow and Steven L. Chang, Brigham and Women's Hospital, Harvard Medical School; Anna Orsola, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and Joaquim Bellmunt, University Hospital del Mar d'Investigacions Médiques, IMIM, Barcelona, Spain. · Pubmed 25559810
2013
  • Laboratoy Recerca IMIM, University Hospital del Mar, Barcelona, Spain. · Pubmed 23851383
Universitat Autonoma de Barcelona
2014
  • Department of Medical Oncology, University Hospital del Mar-IMIM, Barcelona, Spain Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, USA. · Department of Urology, Vall d'Hebron University Hospital, Barcelona, Spain. · Department of Radio Oncology, University Hospital Ulm, Ulm, Germany. · Ludwig Boltzmann Institute for Applied Cancer Research, Kaiser Franz Josef- Spital, Vienna, Austria. · Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK. · Pubmed 25096609
2010
  • Department of Urology, Hospital Vall d'Hebron, Barcelona, Spain. · Pubmed 19558557
4 Other Locations Show
Yearly article counts 022511122102
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.